• Bruce D Levy, Patricia J Noel, Michelle M Freemer, Michelle M Cloutier, Steve N Georas, Nizar N Jarjour, Carole Ober, Prescott G Woodruff, Kathleen C Barnes, Bruce G Bender, Carlos A Camargo, Geoff L Chupp, Loren C Denlinger, John V Fahy, Anne M Fitzpatrick, Anne Fuhlbrigge, Ben M Gaston, Tina V Hartert, Jay K Kolls, Susan V Lynch, Wendy C Moore, Wayne J Morgan, Kari C Nadeau, Dennis R Ownby, Julian Solway, Stanley J Szefler, Sally E Wenzel, Rosalind J Wright, Robert A Smith, and Serpil C Erzurum.
• 1 Brigham and Women's Hospital, Boston, Massachusetts.
• Am. J. Respir. Crit. Care Med. 2015 Dec 1;192(11):1366-72.

AbstractAsthma is a common chronic disease without cure. Our understanding of asthma onset, pathobiology, classification, and management has evolved substantially over the past decade; however, significant asthma-related morbidity and excess healthcare use and costs persist. To address this important clinical condition, the NHLBI convened a group of extramural investigators for an Asthma Research Strategic Planning workshop on September 18-19, 2014, to accelerate discoveries and their translation to patients. The workshop focused on (1) in utero and early-life origins of asthma, (2) the use of phenotypes and endotypes to classify disease, (3) defining disease modification, (4) disease management, and (5) implementation research. This report summarizes the workshop and produces recommendations to guide future research in asthma.

14 keywords...

hide…